Pfizer shareholders may finally get the bargain of their dreams in Seagen.

The cancer drug maker's innovative approach makes it an attractive acquisition candidate for a pharmaceutical behemoth. According to reports, pharmaceutical giant Pfizer Inc. is negotiating an acquisition that would please the company's investors. The Wall Street Journal reported last nig...

The United Arab Emirates plans to track pharmaceuticals electronically from the point of manufacture to the point of usage

The Ministry of Health and Prevention (MoAHP) has organised a four-day workshop to review the latest advancements on 'Tatmeen,' a track-and-trace digital platform aimed at strengthening and securing the UAE's healthcare supply chain.

Tatmeen, which was launched by MoHAP, pro...

The ominous history of chemical weapons

However, war is war. The deadly hatred that characterises it implies opposing armies will use everything at their disposal to defeat the opponent. As a result, the Allies took Putin's threat to deploy chemical weapons in Ukraine seriously. Sarin and tabun, two very poisonous chemicals, are un...

Pharmaceutical reported top-line growth and a return to profitability on the bottom line

Gulf Pharmaceutical Industries (Julphar), situated in Ras Al Khaimah (RAK), has released its financial results for 2021. The firm recorded sales of Dhs1,143m, a 100% increase over the Dhs573m received in 2020.

The pharma firm credited the considerable gain to increasing market share in ...

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market to Witness 8.7% Growth during 2021 - 2029

The Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is projected to grow at a CAGR of 8.7% during the forecast period (2021 – 2029).  The global pharmaceutical contract sales outsourcing (CSO) market is driven by the changing nature of the pharmaceutical industry with new...

Ono Pharmaceutical agrees to pay 28 billion yen and settle lawsuit with Tasuku Honjo

Ono Pharmaceutical Co. has agreed to pay 5 billion yen to Tasuku Honjo and they are also donating money for his research fund.

Highlights

• Ono Pharmaceutical Co and Tasuku Honjo settle lawsuit
• The company has agreed to pay 5 billion yen to Ho...

Global Active Pharmaceutical Ingredient Market to Grow at Promising

The global active pharmaceutical ingredient market reached a robust valuation of US$ 172.14 billion in 2020. The market will exhibit strong growth, rising at 6% CAGR during the forecast (2021-2029) period. Companies such as Sanofi planned to create a major European company dedicated to the produc...

Japan receives around 180,000 contaminated shots of Moderna vaccine, halts immunization

HIGHLIGHTS

•  Japan receives contaminated vaccine shots of Moderna vaccine
• 180,000 vaccine sots are assumed to be contaminated

The Japanese health ministry had given Emergency use approval to Moderna in May this y...

Global Pharmaceutical Quality Control Market was Valued at

Absolute Markets Insights (AMI) reports a robust forecast for the pharmaceutical quality control market during the 2021-2029 period. In its newly released report, AMI anticipates the market will grow at 13.85% as minimized disruption, transit time and costs are rapidly leading the market towards ...

India to likely to start exporting vaccines by 2022 to other nations

The Indian government is planning to submit to start exporting vaccines by 2022, once it is done with the immunization of its own adult population. There are around 60 countries, who do not have access to any vaccine.

India is one of the major vaccine production countries in the world. ...

Oncology Pharmaceuticals Market to Grow at 11.9% CAGR during 2021-2029

Oncology is defined as study of different types of tumors and cancers such as brain tumor, blood cancer, along with its types such as anemia, hemophilia, leukemia, lymphomas, thalassemias, and cancer of other organs, with the intention of finding an effective cure and means of treatment of a part...

TOKYO STOCKS END MIXED OVER APPROVAL OF ALZHEIMER’S DRUG

Highlights –

• Tokyo stocks end mixed over approval of Alzheimer’s drug.
• The 225-issue Nikkei Stock Average ended down 55.68 points, or 0.19 percent.
• Topix index of all First Section issues on the TSE finished 1.80 points, or 0.09...

JAPAN HEALTH MINISTRY PANEL APPROVES PFIZER VACCINE FOR 12-15 YEAR OLDS

Highlights –

• Japan health ministry panel approves Pfizer vaccine for 12-15 year olds.
• The panel also gave the green light to extending the vaccine's maximum storage period.
• Pfizer has been working with the Pharmaceuticals and Medi...

JBCPL NOW HAS A PRESENCE IN INDIAN NEPHROLOGY SEGMENT

HIGHLIGHTS

• J.B. Chemicals & Pharmaceuticals Ltd. (JBCPL) enters the Nephrology segment in India
• RENOVA division of JBCPL caters to the needs of Chronic Kidney Disease patients in India.

J.B. Chemicals & Pharmaceuticals Ltd. (...

JAPAN PHARMACEUTICAL ASSOCIATION OPPOSES TEMPORARY WAIVER OF PATENT ON VACCINE

Highlights –

• Japan pharmaceutical association opposes temporary waiver of patent on vaccine.
• It opposed U.S support for the temporary waiver of coronavirus vaccine patent rights.
• WTO is currently discussing the waiver of patent rights...

REAL-TIME PRESCRIPTION MONITORING SYSTEM IMPLEMENTED IN SOUTH AUSTRALIA

HIGHLIGHTS

• South Australia has implemented real-time prescription monitoring system.
• Now South Australia is the second state in Australia to introduce an initiative to enable high-risk medicines monitoring.

A real-time prescription m...

CHINA TO PRODUCE COVID-19 VACCINE FOR 70% OF ITS POPULATION

Highlights –

• China to produce COVID-19 vaccine for 70% of its population.
• China is trying to reshape its pharmaceutical industry.
• More than 100 million doses had been exported by March.
• Biotec has produced 250 million doses...

REATA PHARMACEUTICALS TO MAKE PRESENTATIONS AT UPCOMING MEDICAL CONFERENCES

HIGHLIGHTS

• Reata Pharmaceuticals Inc. is going to make presentations at upcoming medical conferences.
• Two conferences are going to take place in APR 2021 and JUNE 2021.

A clinical-stage biopharmaceutical company called Reata Pharmace...

CELLTRION WILL SUPPLY ITS COVID-19 TREATMENT WITHOUT PROFIT MARGIN IN S. KOREA

Highlights –

• Celltrion will supply its COVID-19 treatment without profit margin in S. Korea.
• Celltrion’s CT-P59 began to be supplied to local medical institutions on Wednesday.
• The company has also planned to supply the treatmen...

CELLTRION’S COVID-19 ANTIBODY TREATMENT CONFIRMED TO NEUTRALIZE VIRUS VARIANT

Highlights –

• Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
• The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
• The company has also t...